Specimen Collection Study Protocol
NCT04468386 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 47
Last updated 2021-11-24
Summary
The specimens collected will be used to evaluate matrix equivalency in an immunoassay in development for the detection of IgG or IgA or IgM antibodies to SARS - CoV2 in human serum. These reagents are for in vitro diagnostic use only.
Conditions
- Focus in on Collecting Paired Specimens for Matrix Equivalency
Sponsors & Collaborators
-
Biomerica
lead INDUSTRY
Principal Investigators
-
Elisabeth Laderman, Ph.D. · Biomerica, Inc.
Eligibility
- Min Age
- 21 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2020-07-07
- Primary Completion
- 2021-05-30
- Completion
- 2021-05-30
Countries
- United States
Study Locations
More Related Trials
-
Rapid SARS-CoV-2 IgG Antibody Testing in High Risk Healthcare Workers
NCT04334876 ·Status: COMPLETED ·Phase: NA
-
Investigational Performance Evaluation of the Nanomix eLab® COVID-19 Rapid Antigen Panel With Samples From COVID-19 Positive and Negative Human Subjects
NCT04667442 ·Status: COMPLETED
-
BinaxNow COVID-19 IgG Rapid Test Device and Antibody Self Test
NCT04959760 ·Status: COMPLETED ·Phase: NA
-
ANTIBODY BASED TESTS FOR SARSCoV-2 COVID-19) - Evaluation of Patients and Healthcare Providers in the Confines of Healthcare Settings
NCT04352764 ·Status: UNKNOWN
-
Acquiring Convalescent Specimens for COVID-19 Antibodies
NCT04342195 ·Status: COMPLETED
-
Research & Evaluation of LumiraDx SARS-CoV-2 (COVID-19) Point of Care Ab Test
NCT04597047 ·Status: UNKNOWN ·Phase: NA
-
Treatment With Investigational Convalescent Plasma and Measure Antibody Levels in Patients Hospitalized With COVID-19
NCT04434131 ·Status: COMPLETED ·Phase: PHASE2
-
COVID-19: A POC Test Under Research & Evaluation
NCT04408066 ·Status: SUSPENDED ·Phase: NA
-
Evaluation of Rapid Diagnostic Solutions, Serological and Molecular Tests for COVID-19
NCT04405492 ·Status: UNKNOWN ·Phase: NA
-
COVID Card Pilot Study to Detect Antibodies to SARS-CoV-2
NCT05196932 ·Status: COMPLETED
-
Comparison of the ID NOW and Accula Point-of-Care Assays for Detection of COVID-19
NCT04403035 ·Status: WITHDRAWN
-
A Normal Donor Sample Collection Study in Healthy Adults
NCT01318863 ·Status: COMPLETED
-
TekiTrust Tests to Determine the Level of SARS-COV-2/COVID-19 Neutralizing Antibodies in the Blood
NCT05338762 ·Status: COMPLETED
-
Healthy Volunteer COVID-19 Antibody Testing Study
NCT04529460 ·Status: WITHDRAWN
-
Apheresis and Specimen Collection Procedures to Obtain Plasma, Peripheral Blood Mononuclear Cells (PBMCs) and Other Specimens for Research Studies
NCT00067054 ·Status: RECRUITING
-
Compliant Analysis of Patient Samples and Data
NCT04364503 ·Status: RECRUITING
-
Utilizing Novel Blood RNA Biomarkers as a Diagnostic Tool in the Identification of Long COVID-19
NCT06311435 ·Status: RECRUITING ·Phase: NA
-
Convalescent Plasma Donor Vaccine Study An Observational Antibody Level Study.
NCT04954937 ·Status: UNKNOWN
-
A Study To Evaluate The Performance of the Lucira Health All-In-One COVID-19 Test Kit vs Hologic Panther Fusion
NCT04720794 ·Status: COMPLETED ·Phase: NA
-
Distribution of Biospecimens From Biorepositories/Biobanks for Research Use
NCT03884400 ·Status: WITHDRAWN
-
At-Home COVID-19 Antibody Test Usability Assessment & Behavior Change Study
NCT04393961 ·Status: UNKNOWN ·Phase: NA
-
Alinity s Anti-HCV II - Clinical Evaluation Protocol
NCT04862065 ·Status: COMPLETED ·Phase: NA
-
Clinical Evaluation of Rapid Antibody Test for Covid-19
NCT05298462 ·Status: COMPLETED ·Phase: NA
-
Convalescent Plasma for the Treatment of Patients With COVID-19
NCT04372368 ·Status: NO_LONGER_AVAILABLE
-
Treatment of Long COVID Symptoms Utilizing Autologous Stem Cells Following COVID-19 Infection
NCT05669261 ·Status: UNKNOWN ·Phase: PHASE1